These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1514249)

  • 1. Immunohistological detection of tissue factor in normal and abnormal human mammary glands using monoclonal antibodies.
    Sturm U; Luther T; Albrecht S; Flössel C; Grossmann H; Müller M
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(2):79-86. PubMed ID: 1514249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family.
    Vrana JA; Stang MT; Grande JP; Getz MJ
    Cancer Res; 1996 Nov; 56(21):5063-70. PubMed ID: 8895765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of human tissue factor in normal mammary epithelial cells and in carcinomas.
    Chen Z; Sager R
    Mol Med; 1995 Jan; 1(2):153-60. PubMed ID: 8529094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumours.
    Bartek J; Taylor-Papadimitriou J; Miller N; Millis R
    Int J Cancer; 1985 Sep; 36(3):299-306. PubMed ID: 2411673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory component in differentiating normal epithelium, benign lesions and malignancy in the human breast as monitored by monoclonal antibodies.
    Bártek J; Tlaskalová-Hogenová H; Stasková Z; Simecková J; Vojtĕsek B; Rejthar A; Kovarík J; Bartková J
    Histochemistry; 1989; 91(3):235-44. PubMed ID: 2722565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.
    Drake TA; Morrissey JH; Edgington TS
    Am J Pathol; 1989 May; 134(5):1087-97. PubMed ID: 2719077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and characterization of monoclonal antibodies showing a different spectrum of reactivity to human breast tissue.
    Mandeville R; Giroux L; Lecomte J; Chausseau JP; Dumas F; Ajdukovic I; Vidal D; Boury F
    Cancer Detect Prev; 1987; 10(1-2):89-100. PubMed ID: 2436777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular localization of tissue factor in human breast cancer cell lines.
    Müller M; Flössel C; Haase M; Luther T; Albrecht S; Nawroth PP; Zhang Y
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(5):265-9. PubMed ID: 8287123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
    Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
    Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12.
    Pellegrino MB; Asch BB; Connolly JL; Asch HL
    Cancer Res; 1988 Oct; 48(20):5831-6. PubMed ID: 2458830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of CD66a (BGP), a cell adhesion molecule of the carcinoembryonic antigen family, in benign, premalignant, and malignant lesions of the human mammary gland.
    Riethdorf L; Lisboa BW; Henkel U; Naumann M; Wagener C; Löning T
    J Histochem Cytochem; 1997 Jul; 45(7):957-63. PubMed ID: 9212821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human mammary gland and breast carcinoma contain immunoreactive inhibin/activin subunits: evidence for a secretion into cystic fluid.
    Di Loreto C; Reis FM; Cataldi P; Zuiani C; Luisi S; Beltrami CA; Petraglia F
    Eur J Endocrinol; 1999 Aug; 141(2):190-4. PubMed ID: 10427163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin intermediate filament expression in benign and malignant breast disease.
    Heatley M; Maxwell P; Whiteside C; Toner P
    J Clin Pathol; 1995 Jan; 48(1):26-32. PubMed ID: 7535804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules.
    Koukoulis GK; Virtanen I; Korhonen M; Laitinen L; Quaranta V; Gould VE
    Am J Pathol; 1991 Oct; 139(4):787-99. PubMed ID: 1928301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a new mucin-type glycoprotein in select epithelial dysplasias and neoplasms detected immunocytochemically with Mab A-80.
    Shin SS; Gould VE; Gould JE; Warren WH; Gould KA; Yaremko ML; Manderino GL; Rittenhouse HG; Tomita JT; Jansson DS
    APMIS; 1989 Dec; 97(12):1053-67. PubMed ID: 2611021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease.
    Contrino J; Hair G; Kreutzer DL; Rickles FR
    Nat Med; 1996 Feb; 2(2):209-15. PubMed ID: 8574967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue.
    Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A
    J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues.
    Costantini V; Sidoni A; Deveglia R; Cazzato OA; Bellezza G; Ferri I; Bucciarelli E; Nenci GG
    Cancer; 1996 Mar; 77(6):1079-88. PubMed ID: 8635127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue Factor Expression Does Not Predict Mortality in Breast Cancer Patients.
    Stämpfli SF; Akhmedov A; Hausladen S; Varga Z; Dedes KJ; Hellermann J; Lüscher TF; Kristiansen G; Tanner FC; Breitenstein A
    Anticancer Res; 2017 Jun; 37(6):3259-3264. PubMed ID: 28551673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vimentin expression in benign and malignant breast epithelium.
    Heatley M; Whiteside C; Maxwell P; Toner P
    J Clin Pathol; 1993 May; 46(5):441-5. PubMed ID: 7686566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.